SL-1002 Clinical Trials (2026): 2 Studies for Osteoarthritis, Knee Pain & Spasticity
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
2 SL-1002 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 2 indications (including Osteoarthritis, Knee Pain & Spasticity) and 164 total planned enrollment. Most recent activity: NCT05470608 (Jan 2024).
SL-1002 clinical trials at a glance: phase × recruitment status
| Phase | unknown | Total |
|---|---|---|
| P2 | 2 | 2 |
SL-1002 clinical trials by indication
Osteoarthritis, Knee Pain (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05470608 | COMPASS | P2 | unknown | Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain |
Spasticity (1)
| NCT | Acronym | Phase | Status | Title |
|---|---|---|---|---|
| NCT05311215 | RAISE | P2 | unknown | Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity |
SL-1002 pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| COMPASS | NCT05470608 | P2 | unknown | Osteoarthritis, Knee Pain | 132 | — |
| RAISE | NCT05311215 | P2 | unknown | Spasticity | 32 | — |
All SL-1002 trials (2)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT05470608 | COMPASS | Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain | P2 | unknown | 132 | Saol Therapeutics Inc | Jun 2022 |
| NCT05311215 | RAISE | Phase II Study to Assess Safety, Pharmacokinetics and Efficacy of SL-1002 for Limb Spasticity | P2 | unknown | 32 | Saol Therapeutics Inc | Apr 2022 |
SL-1002 clinical trials: frequently asked questions
- How many SL-1002 clinical trials are there?
- 2 SL-1002 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are SL-1002 clinical trials recruiting in 2026?
- No active SL-1002 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is SL-1002 being studied for?
- SL-1002 is being studied for Osteoarthritis, Knee Pain, Spasticity. The trials are grouped by indication on this page.
- What phase is SL-1002 in?
- SL-1002 clinical trials span 2 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors SL-1002 clinical trials?
- The lead sponsor across the most SL-1002 trials is Saol Therapeutics Inc. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming SL-1002as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: